Table 1.
Characteristics of Patients Included in the Study
| Gender | Age | Variant | TNM staging | Presentation of metastatic lesions | Imaging tests performed |
|---|---|---|---|---|---|
| M | 56 | Diffuse sclerosis | T3N1M0 | Mediastinum | Cervical/chest CT |
| M | 20 | Follicular | T3mN1bM1 | Lung | Chest CT |
| F | 51 | Follicular | T3N1M0 | Mediastinal lymphonode | Cervical CT |
| F | 35 | Follicular | T1N1M1 | Mediastinal lymphonode | Cervical CT |
| F | 34 | Classic | T4bN1bM0 | Mediastinal lymphonode | Cervical CT |
| F | 37 | Trabecular | T2mN1M0 | Cervical lymphonode | Cervical CT |
| F | 17 | Classic | T3mN1M0 | Cervical lymphonode | Cervical CT |
| F | 32 | Classic | T3mN1Mx | Cervical lymphonode | Cervical CT |
| F | 57 | Classic | T2N1bM1 | Lung | Chest CT |
| F | 26 | Follicular | T1mN1bM0 | Cervical lymphonode | Cervical CT |
| F | 28 | Follicular | T3N1M0 | Lung | Chest CT |
| F | 42 | Classic | T1mN1M1 | Cervical lymphonode | Cervical CT |
| M | 50 | Follicular | T2N1M0 | Cervical lymphonode | Cervical CT |
| F | 25 | Classic | T2N1bM0 | Cervical lymphonode | Cervical CT |
| F | 22 | Follicular | T2mN1bM1 | Lung | Chest CT |
| F | 28 | Classic | T3N1M0 | Cervical lymphonode | Cervical CT |
| M | 47 | Classic | T3N1bM1 | Cervical/mediastinal lymphonode | Cervical/chest CT |
| F | 34 | Classic | T3N1M0 | Cervical lymphonode | Cervical CT |
| M | 25 | Classic | T4N1M1 | Lung | Cervical/chest CT |
| M | 38 | Classic | T1N1bMx | Cervical lymphonode | Cervical CT |
| F | 63 | Follicular | T2N1M1 | Lung | Chest CT |
| F | 57 | Classic | T2N1bM1 | Lung | Chest CT |
| F | 28 | Classic | T3N1M0 | Lung | Chest CT |
| F | 24 | Follicular | T3N1bM1 | Lung | Chest CT |
| F | 55 | Classic | T3N1bM1 | Lung and bone | Cervical/spine/chest CT |
Variant, papillary thyroid carcinoma variant on surgical pathology diagnosis; CT, computed tomography.